Clinical Trial Update: Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler® [Phase 3]

View source ↗

Summary

Phase 3 trial assessing PT010, PT003, and PT009 versus Symbicort in Japanese subjects with COPD; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT003
• PT009
• PT010
• Symbicort Turbohaler (budesonide/formoterol)

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2020-05-13